BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11907744)

  • 1. Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization.
    Terayama N; Matsui O; Gabata T; Kobayashi S; Sanada J; Ueda K; Kadoya M; Kawamori Y
    Cardiovasc Intervent Radiol; 2001; 24(6):383-7. PubMed ID: 11907744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of emulsion containing Gd-DTPA and lipiodol in hepatic transcatheter arterial embolization.
    Shiono T; Yoshikawa K; Hisamatsu K; Takenaka E
    Radiat Med; 1993; 11(5):187-90. PubMed ID: 8290693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
    Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma].
    Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma.
    Khan KN; Nakata K; Kusumoto Y; Shima M; Ishii N; Koji T; Nagataki S
    Cancer Res; 1991 Oct; 51(20):5667-71. PubMed ID: 1717151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multidisciplinary therapy of hepatocellular carcinoma--TAI. TAE treatment by intra-arterial catheterization].
    Shimamura Y; Shimizu H; Takenaka Y; Akimoto H; Shima Y; Arima K; Takahashi A; Kitaya T; Matsuyama T; Hasegawa H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1596-602. PubMed ID: 3015035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
    Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
    Takekoshi H; Oyama R
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH; Lee WJ; Lim HK; Lim JH
    J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
    Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytofluorometric and histopathological studies on non-cancerous liver lesions after lipiodol-transcatheter arterial embolization].
    Shimotsuma M; Taniguchi H; Sawai K; Takahashi T; Kagawa K; Kamachi M; Ashihara T; Shimamura Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2460-4. PubMed ID: 2843109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.